← Open Payments lookup

CHELSEA KROUSE: Open Payments

NPI 1588191332 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$385 in 27 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $385

Food & beverage: $385
CompanyPaymentsAmount
ABBVIE INC.12$152
Bayer Healthcare Pharmaceuticals Inc.2$35
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$34
Lilly USA, LLC2$31
AstraZeneca Pharmaceuticals LP2$31
Corium, LLC1$17
Otsuka America Pharmaceutical, Inc.1$16
Exact Sciences Corporation1$15
Boehringer Ingelheim Pharmaceuticals, Inc.1$15
Amgen Inc.1$15

Products named: UBRELVY, VRAYLAR, Kerendia, CAPLYTA, MOUNJARO, LINZESS, QULIPTA, AIRSUPRA.

Industry payments across IN — which companies pay providers there.